or Try an Advanced Search...

    Respiratory Diseases Stocks List

    Symbol Grade Name % Change
    SPRY C ARS Pharmaceuticals, Inc. -3.92
    ALVO C Alvotech 3.26
    AZN A Astrazeneca PLC 2.68
    EHAB F Enhabit, Inc. 3.58
    GILD F Gilead Sciences, Inc. -0.90
    MRK B Merck & Company, Inc. -0.18
    REVB F Revelation Biosciences, Inc. -1.31
    SVRA D Savara, Inc. 3.12
    SMLR F Semler Scientific, Inc. 0.26
    TBPH C Theravance Biopharma, Inc. 0.22
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
    Related Stock Lists: Medicine Disease Infection Respiratory Therapy Allergology Angina Antibiotics Asthma Biopharmaceutical Cardiovascular Disease Chronic Obstructive Pulmonary Disease Coronavirus Cystic Fibrosis Diabetes Hypertension Inflammation Medication Nasal Administration Nasdaq 100 S&P 500

    Related ETFs - A few ETFs which own one or more of the above listed Respiratory Diseases stocks.

    Symbol Grade Name Weight
    IBBQ B Invesco Nasdaq Biotechnology ETF 12.32
    PPH A Market Vectors Pharmaceutical ETF 12.08
    MEDX C Horizon Kinetics Medical ETF 10.95
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 10.94
    PJP A PowerShares Dynamic Pharmaceuticals 9.12
    View all Respiratory Diseases ETFs...
    Compare ETFs
    Compare IBBQ to PPH Compare MEDX to FTXH Compare MEDX to PJP

        Respiratory Diseases Stocks Recent News

        Date Stock Title
        May 21 EHAB Enhabit Announces Participation in Upcoming Goldman Sachs 45th Annual Global Healthcare Conference
        May 21 AZN AstraZeneca’s $80B sales plan leans on cancer drug expansion
        May 21 ALVO Stocks Hold Steady On Mixed Fed Remarks, First Solar Rallies, Bitcoin Falls Below $70,000: What's Driving Markets Tuesday?
        May 21 AZN AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
        May 21 AZN European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030
        May 21 AZN AstraZeneca sets sights on $80B in revenue by 2030
        May 21 AZN AstraZeneca projects $80B in revenue by 2030
        May 21 AZN AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
        May 21 TBPH Theravance Biopharma First Quarter 2024 Earnings: Beats Expectations
        May 21 AZN Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher
        May 21 AZN AstraZeneca to establish $1.5bn ADC production site in Singapore
        May 21 AZN Lowe's, Macy's, Xpeng rise premarket; Palo Alto, Zoom fall
        May 21 AZN AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
        May 21 AZN AstraZeneca shares rise as pharma group unveils 2030 revenue target
        May 21 AZN AstraZeneca aims for $80 billion in total revenue by 2030
        May 21 AZN AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
        May 21 AZN European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target
        May 20 AZN Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
        May 20 EHAB Enhabit Announces Participation in Upcoming Leerink Partners Healthcare Crossroads Conference 2024
        May 20 AZN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
        Related Stock Lists: Medicine Disease Diabetes Hypertension Infection Allergology Angina Antibiotics Biopharmaceutical Cancer Cardiovascular Disease Chronic Condition Chronic Disease Coronavirus Cystic Fibrosis Heart Disease Heart Failure Inflammation Life Sciences Medication
        Respiratory Diseases

        Respiratory diseases are a group of conditions that affect the lungs and airways. These diseases can range from mild to severe and can include asthma, COPD, pneumonia, and lung cancer. Symptoms of respiratory diseases can include difficulty breathing, coughing, wheezing, and chest pain. Treatment for respiratory diseases can include medications, lifestyle changes, and surgery.

        Browse All Tags